Columbia Technology Ventures
Small Molecule
Active Filters
Assay
4 results
(0.03 seconds)

This technology describes the synthesis and characterization of small molecule NT5C2 inhibitors for the treatment of relapsed and chemotherapy-resistant acute lymphoblastic leukemia (ALL) and T-cell acute lymphoblastic leukemia (T-ALL).